Navigation Links
New Resource Available for People With Lymphoma
Date:8/19/2007

FAIRFAX, Va., Aug. 2 /PRNewswire-USNewswire/ -- The American Society for Therapeutic Radiology and Oncology has published the brochure Radiation Therapy for Lymphoma, a short treatment guide to assist people coping with Hodgkin's and non-Hodgkin's lymphoma. The brochure outlines the major differences between the diseases, explains radiation therapy's role in treatment and what patients can expect before, during and after radiation therapy.

"A cancer diagnosis can be very frightening and confusing for patients and their families, especially with such a diverse disease like lymphoma," said Thomas Eichler, M.D., Chair of ASTRO's Communications Committee and a radiation oncologist at the Thomas Johns Cancer Center in Richmond, Va. "It is our hope that this brochure will guide patients with lymphoma through the various treatment options available to them, including the role of radiation therapy, in order to make an informed decision on their care."

This four-color brochure is the newest component in ASTRO's award-winning public awareness campaign that consists of 17 brochures in English and Spanish. Brochures can be downloaded for free on RTanswers.org and hard copies can be purchased by visiting http://www.astro.org/shop/.

For a free sample copy of the brochure, e-mail communications@astro.org.

ASTRO is the largest radiation oncology society in the world, with 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.


'/>"/>
SOURCE American Society for Therapeutic Radiology and Oncology

Copyright©2007 PR Newswire.

Page: 1

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
3. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
4. Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
5. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
7. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
8. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
9. Dean: President Bush Has Turned His Back on the American People
10. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
11. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... Minn. , July 20, 2017  Prime Therapeutics LLC ... Jonathan Gavras , M.D., following today,s Institute for Clinical and ... report on the effectiveness and value of abuse-deterrent formulations ... on the policy roundtable at the meeting. ... not a material cost benefit to the use of abuse-deterrent ...
(Date:7/14/2017)... -- It should come as no surprise to anyone that ... midst of a crippling opioid epidemic. According to the ... overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... from 2001 to 2015". During this time, the prescription rate ... drawing a compelling link between prescription and eventual addiction. The ...
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... ... cats has opened in Jupiter. The state of the art center will ... leading treatments with a goal of providing heart patients longer lives. , North ...
(Date:7/26/2017)... FL (PRWEB) , ... July 26, 2017 , ... ... nation’s leading innovative specialty pharmacies, has released an updated version of the HCV ... latest guidelines for treating chronic hepatitis C virus (HCV) infection. All of the ...
(Date:7/25/2017)... MOORE, OK (PRWEB) , ... July 25, 2017 ... ... are proud to announce the launch of their partnership to provide the ... is the first pharmacy-focused platform in the country with the ability to develop ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina ... Negrette has more than a decade of experience in psychiatry, treating clients in ... fighting addictions, eating disorders, psychotic and manic conditions, as well as those who ...
(Date:7/24/2017)... ... July 24, 2017 , ... Contact: ... Robins & Morton, Perkins Will, Newcomb & Boyd, Walter P Moore and ... new Destination Medical Building located at Mayo Clinic in Jacksonville, Florida. , ...
Breaking Medicine News(10 mins):